Baker McKenzie advised Marel on the deal. Marel, a multi-national food processing company based in Iceland, entered into a transaction agreement with John Bean Technologies Corporation (NYSE: JBT)...
You must be a Standard 1 Year member to access this content.
Baker McKenzie acted as legal counsel to Takeda. Takeda signed a worldwide license and collaboration agreement with Protagonist Therapeutics, Inc., for the development and commercialization of...
You must be a Standard 1 Year member to access this content.
Baker McKenzie advised Mysten Labs, Inc. on the deal. Mysten Labs, Inc. executed the acquisition of certain assets from SuiNS Technologies Inc., an open, distributed naming...
You must be a Standard 1 Year member to access this content.
Baker McKenzie advised Abbott Laboratories on the deal. Abbott Laboratories executed the acquisition of Cardiovascular Systems, Inc. in an all-cash transaction valued at approximately $890 million. ...
You must be a Standard 1 Year member to access this content.
Baker McKenzie advised Minoryx Therapeutics on the deal. Clifford Chance advised the Neuraxpharm Group. Minoryx Therapeutics, a late-stage biotech company focused on the development of treatments...
You must be a Standard 1 Year member to access this content.
Baker McKenzie advised Yageo Corporation on the deal. Deloitte Société d’Avocats advised Schneider Electric. Yageo Corporation executed the acquisition of Telemecanique Sensors business from Schneider Electric (SU.PA)....
You must be a Standard 1 Year member to access this content.
Baker McKenzie advised Affirm Holdings, Inc. on the deal. Affirm Holdings, Inc. completed the acquisition of Returnly, a leader in online return experiences and post-purchase payments....
You must be a Standard 1 Year member to access this content.
